Obesity raises the odds of developing cardiovascular disease, type 2 diabetes, stroke, certain malignancies, sleep apnea, and lung diseases
It may be especially helpful for patients who plateau during GLP-1 therapy or want additional support targeting excess body fat while preserving lean muscle
Well also highlight expanding therapeutic applications for GLP-1 RAs, preparing clinicians to make evidence-based recommendations in this rapidly evolving landscape
I was just eating healthier, I was exercising, it was like a switch just flipped. That was nearly four years ago
But the ones youve heard about lately are a lot different
Semaglutide 24 Mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial